Journals / Türk Kolon ve Rektum Hastalıkları Dergisi / 2018 / Cilt: 28 - Sayı: 1

Kolorektal Kanser Tarama lı Yapılan Gaytada Gizli Kan Testi Pozitif Saptanan Hastalarda Kolonoskopi Bulguları

Colonoscopy Findings in Patients Who Have Positive Fecal Occult Blood Test for Colorectal Cancer Screening

Pages
27–30
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Informing patients about the need for colonoscopy and encouraging them to have colonoscopy will be helpful for the success of colorectal screening programs

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To determine the rate of colonoscopies performed in patients referred for colonoscopy due to positive fecal occult blood test in colorectal cancer screening, and the rates of cancer, polyps, and other colorectal diseases detected in those who underwent colonoscopy.Method: Colonoscopy results of the patients were recorded prospectively.Results: Of the 300 consecutive patients scheduled for colonoscopy, only 127 (42.3%) underwent the procedure.
📊
Key Findings & Data:Normal colonoscopy findings were seen in 47 (37%) of the patients.
💡
Conclusion & Impact:Informing patients about the need for colonoscopy and encouraging them to have colonoscopy will be helpful for the success of colorectal screening programs
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To determine the rate of colonoscopies performed in patients referred for colonoscopy due to positive fecal occult blood test in colorectal cancer screening, and the rates of cancer, polyps, and other colorectal diseases detected in those who underwent colonoscopy.Method: Colonoscopy results of the patients were recorded prospectively.Results: Of the 300 consecutive patients scheduled for colonoscopy, only 127 (42.3%) underwent the procedure. Normal colonoscopy findings were seen in 47 (37%) of the patients. Forty patients (31.5%) had benign polyps, 24 (18.9%) had diverticulosis, and 40 (31.5%) had hemorrhoids or anal fissures. One patient (0.8%) had mild dysplasia and one patient (0.8%) had malignant polyp in histopathologic examination of polypectomy specimen.Conclusion: The colonoscopy rate and the rate of detection of malignancy were very low in patients who had positive fecal occult blood test in the present study. Informing patients about the need for colonoscopy and encouraging them to have colonoscopy will be helpful for the success of colorectal screening programs

Özet

Amaç: Kolorektal kanser tarama amaçlı yapılan gaytada gizli kan testinde pozitiflik saptanarak kolonoskopi yapılan hastalarda kolonoskopi yapılma oranı, kanser, polip ve diğer kolorektal hastalık oranlarını ortaya çıkarmak amaçlanmıştır.Yöntem: Çalışmaya alınan hastaların kolonoskopi sonuçları prospektif olarak kayıt altına alındı.Bulgular: Kolonoskopi planlanan ardışık 300 hastanın sadece 127'si (%42,3) kolonoskopiyi kabul etti ve yaptırdı. Hastaların 47'sinde (%37) kolonoskopi normal idi. Kırk (%31,5) hastada benign polip, 24 (%18,9) hastada divertiküler hastalık, 40 (%31,5) hastada hemoroid veya anal fissür izlendi. Polip saptanan ve polipektomi yapılan hastalarda histopatolojik inceleme sonucunda bir (%0,8) hastada hafif şiddette displazi ve bir (%0,8) hastada malign polip saptandı.Sonuç: Gaytada gizli kan pozitifliği saptanan hastalarda kolonoskopi yaptırma oranı ve malignite saptanma oranı çok düşük bulunmuştur. Hastaların kolonoskopinin gerekliliği konusunda bildirilmesi ve kolonoskopi yaptırılmaya teşvik edilmesi kolorektal tarama programlarının başarıya ulaşmasında faydalı olacaktır

🔖

Cite This Article

MAYİR, B., ENSARİ, C. Ö., DURHAN, A., ÇÖPELCİ, Y. (2022). Kolorektal Kanser Tarama lı Yapılan Gaytada Gizli Kan Testi Pozitif Saptanan Hastalarda Kolonoskopi Bulguları. Türk Kolon ve Rektum Hastalıkları Dergisi, Cilt: 28 - Sayı: 1, 27–30. https://ajindex.com/articles/634644

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. www.saglik.gov.tr/Eklenti/8635,kanser-istatistikleridocx.docx?0 2. http://www.wcrf.org/int/cancer-facts-figures/worldwide-data 3. KOLOREKTAL KANSER TARAMALARI http://kanser.gov.tr/Dosya/ tarama/kolorektal_kanser_tarama_programi.pdf 4. http://kanser.gov.tr/Dosya/tarama/kolorektal.pdf 5. Çakmur H, Anuk T, Önder T, Güven H, Köksal N. Kuzey-Doğu Anadolu Bölgesinde Görülen Kolorektal Kanserlerin Özellikleri. Turk J Colorectal Dis 2015;25:21-27. 6. Özkan ÖF, Kaya Ü, Güner A, Cevizci S, Özkul F, Sezer C, Reis E. Bir eğitim ve araştırma hastanesinde kolorektal kanser hastalarının demografik dağılımı ve hastalık özellikleri. Pam Tıp Derg 2012;5:132-135. 7. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;24:CD001216. 8. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FAR, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Owens DK, Phillips WR, Phipps MG, Pignone MP, Siu AL. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force. JAMA 2016;315:2564-2575. 9. Bailey JR, Aggarwal A, Imperiale TF. Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities. Gut Liver 2016;10:204-211. 10. Bray C, Bell LN, Liang H, Collins D, Yale SH. Colorectal Cancer Screening. WMJ 2017;116:27-33. 11. Rodriguez-Montes JA, Menendez Sanchez P. Role of micro-RNA in colorectal cancer screening. Cir Esp 2014;92:654-658. 12. Kobaek-Larsen M, Kroijer R, Dyrvig AK, Buijs MM, Steele RJC, Qvist N, Baatrup G. Back-to-back colon capsule endoscopy and optical colonoscopy in colorectal cancer screening individuals. Colorectal Dis 2017. [Epub ahead of print] 13. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014,
  2. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2014 14. von Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary. Endoscopy 2012;44 Suppl 3:SE1-8. 15. Lin JS, Piper MA, Perdue LA, Rutter CM, Webber EM, O’Connor E, Smith N, Whitlock EP. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2016;315:2576-259